Multifocal CONTROL/TEST for Visual Acuity

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
The University of Georgia, Athens, GAVisual AcuityACUVUE OASYS 1-Day for Astigmatism - Device
Eligibility
18 - 70
All Sexes
What conditions do you have?
Select

Study Summary

This is a 2-phase, single-site, non-dispensing, randomized, controlled, double-masked, 2x2 crossover study to objectively measure potential benefits of a new UV/HEV filter using psychophysical testing techniques.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

2
Artisan Aphakia Intraocular Lens
3
NaturalVue Multifocal
1
Artisan Aphakia Intraocular Lens

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: up to 2-week follow-up

up to 2-week follow-up
Brightness Perception
Motion Detection
Visual Range

Trial Safety

Safety Progress

1 of 3

Similar Trials

3
Artisan Aphakia Intraocular Lens
3
NaturalVue Multifocal
1
Artisan Aphakia Intraocular Lens

Trial Design

6 Treatment Groups

Multifocal CONTROL/TEST
1 of 6
Sphere CONTROL/TEST
1 of 6
Toric CONTROL/TEST
1 of 6
Sphere TEST/CONTROL
1 of 6
Multifocal TEST/CONTROL
1 of 6
Toric TEST/CONTROL
1 of 6

Experimental Treatment

167 Total Participants · 6 Treatment Groups

Primary Treatment: Multifocal CONTROL/TEST · No Placebo Group · N/A

Multifocal CONTROL/TESTExperimental Group · 2 Interventions: ACUVUE OASYS Multifocal, ACUVUE OASYS MAX 1-Day Multifocal · Intervention Types: Device, Device
Sphere CONTROL/TESTExperimental Group · 2 Interventions: ACUVUE OASYS 1-Day, ACUVUE OASYS MAX 1-Day · Intervention Types: Device, Device
Toric CONTROL/TESTExperimental Group · 2 Interventions: ACUVUE OASYS 1-Day for Astigmatism, senofilcon A based contact lens (toric) with new UV/HEV filter · Intervention Types: Device, Device
Sphere TEST/CONTROLExperimental Group · 2 Interventions: ACUVUE OASYS 1-Day, ACUVUE OASYS MAX 1-Day · Intervention Types: Device, Device
Multifocal TEST/CONTROLExperimental Group · 2 Interventions: ACUVUE OASYS Multifocal, ACUVUE OASYS MAX 1-Day Multifocal · Intervention Types: Device, Device
Toric TEST/CONTROLExperimental Group · 2 Interventions: ACUVUE OASYS 1-Day for Astigmatism, senofilcon A based contact lens (toric) with new UV/HEV filter · Intervention Types: Device, Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ACUVUE OASYS 1-Day for Astigmatism
2022
N/A
~130
ACUVUE OASYS 1-Day
2021
N/A
~300

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 2-week follow-up

Who is running the clinical trial?

Johnson & Johnson Vision Care, Inc.Lead Sponsor
209 Previous Clinical Trials
24,951 Total Patients Enrolled
83 Trials studying Visual Acuity
8,324 Patients Enrolled for Visual Acuity
Johnson & Johnson Vision Care, Inc. Clinical TrialStudy DirectorJohnson & Johnson Vision Care, Inc.
37 Previous Clinical Trials
3,825 Total Patients Enrolled
29 Trials studying Visual Acuity
3,353 Patients Enrolled for Visual Acuity

Eligibility Criteria

Age 18 - 70 · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Is it possible to participate in this medical trial?

"This trial requests 167 patients with visual acuity of 20/25 or better, aged 18 to 70 years. Necessary criteria include: wearing soft contact lenses for at least 6 hours per day, 5 days a week in the past 30 days; refraction within -1.00 and -6.00 diopters sphere (for spherical lenses); refraction within -1.50 and -4.00 diopters sphere/-0.625 and 1-625 cylinder (for toric lenses), axis 80°/90°/100° 170°/180°/10°; comprehension and signed consent form agreement; ability" - Anonymous Online Contributor

Unverified Answer

Is it still possible to obtain a place in this medical experiment?

"Indications from clinicaltrials.gov suggest that the recruitment phase for this medical trial has closed; it was first posted on November 4th 2022 and last updated two weeks ago. Fortunately, there are 5 other studies actively admitting patients at present." - Anonymous Online Contributor

Unverified Answer

Are any adults over the age of forty being enlisted in this investigation?

"This clinical trial requires that potential participants are at least 18 years of age and no older than 70, as outlined in the eligibility requirements." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top